Paul R. Flynn

Companies

• DexcomEVP, Global Revenue Apr 1, 2021 to Dec 19, 2023¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Dexcom DXCM48,949 shares²$4.2M at $86.09Dec 18, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Dec 18, 2023Returned to company 3,163 shares at $121.85 of Dexcom²
• Apr 17, 2023Sold 2,781 shares at $120.00 of Dexcom³
• Mar 13, 2023Sold 2,782 shares at $106.27 of Dexcom⁴
• Mar 10, 2023Returned to company 5,643 shares at $111.40 of Dexcom⁴
• Mar 10, 2023Returned to company 5,724 shares at $111.40 of Dexcom⁴
• Mar 10, 2023Returned to company 5,478 shares at $111.40 of Dexcom⁴
• Mar 8, 2023Granted 18,776 shares of Dexcom⁵
• Dec 8, 2022Sold 8,988 shares at $123.50 of Dexcom⁶
• Mar 9, 2022Returned to company 784 shares at $406.06 of Dexcom⁷
• Mar 9, 2022Returned to company 1,114 shares at $406.06 of Dexcom⁷
• Mar 9, 2022Returned to company 1,069 shares at $406.06 of Dexcom⁷
• Mar 8, 2022Granted 5,297 shares of Dexcom⁷
• Dec 15, 2021Granted 2,925 shares of Dexcom⁸